InspireMD promotes Andrea Tommasoli to COO, effective March 19, 2023

InspireMD, Inc.

Tommasoli previously served as SVP of Global Sales & Marketing since November 2020.
New annual base salary of €240,000 (≈ $258,000) plus yearly bonus of 35% of base salary.
CEO Marvin Slosman cited Tommasoli's role in expanding CGuard EPS in EU and preparing for U.S. approval.
Tommasoli has prior commercial leadership at Integra LifeSciences and St. Jude Medical (Abbott).
Employment agreement has indefinite term with six months' notice period for termination.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Andrea Tommasoli

Chief Operating Officer

NSPR · InspireMD, Inc.

Effective: 2023-03-19
Filed: March 20, 2023, 7:59 PM ET

On March 19, 2023, InspireMD, Inc. (the “Company”), announced that its Board of Directors (the “Board”) promoted Andrea Tommasoli to Chief Operating Officer of the Company, effective as of March 19, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrea Tommasoli changed role as Chief Operating Officer at InspireMD, Inc..

Action: promoted
Role: Chief Operating Officer

Exact text from the filing

On March 19, 2023, InspireMD, Inc. (the “Company”), announced that its Board of Directors (the “Board”) promoted Andrea Tommasoli to Chief Operating Officer of the Company, effective as of March 19, 2023.

View on SEC.gov

InspireMD, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-008192

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.